Age and Sex-Specific PREValence of AcqUirEd VALVular Heart DiseasE

Running, not enrolling

Conditions studied: Valvular Heart Disease

In brief

The PREVUE-VALVE study will establish reliable, population-based estimates of Valvular Heart Disease (VHD) prevalence among older Americans and allow for the development and validation of several innovative tools to aid in the detection and diagnosis of Valvular Heart Disease (VHD).

Key facts

Study ID

NCT05357404

Run by

Cardiovascular Research Foundation, New York

People needed

2870

Starts

2022-04-21

Expected to finish

2025-04-01

Last updated by the study team

2025-02-07

Who can join

Age: 65 and older, up to 85. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Age 65-85
• Ability to provide informed consent
• Stably domiciled in a residence that can be accessed by study personnel

You may not qualify if…

• History of complex congenital heart disease

Where it is running

• Hawthorne Effect — Walnut Creek, California, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.